2025-12-22 – Weekly Healthcare News : RSV cases on the rise again

Last week, our community engaged in a series of insightful discussions. Members explored the increasing cases of RSV and its implications, shared tidbits about unique anatomical features like the muscle-free talus, and debated the role of technology in eConsent with robust audit trails. Additionally, there was a lively exchange on how veterinary technicians’ skills translate into human healthcare settings. These conversations reflect our collective efforts to stay informed and adaptive in a rapidly evolving healthcare landscape.


This Week’s Hot Topics

RSV is picking up again
The forum is buzzing with updates on the resurgence of RSV. Members are sharing observations and strategies for managing the uptick in cases, which is critical as we enter the colder months.

Read more here

Ankle trivia: the talus has no muscle attachments
This thread delves into the fascinating anatomy of the ankle, focusing on the talus bone. It’s a reminder of the complexities and surprises within human anatomy.

Read more here

eConsent with monitor-friendly audit trails
There’s an ongoing conversation about enhancing eConsent processes with technology that ensures easy monitoring. This could be a game-changer for clinical trials.

Read more here

Vet tech skills that carry into healthcare
A fascinating discussion on how skills from veterinary technology can be applied to human healthcare. It’s a unique perspective on cross-disciplinary skill application.

Read more here

Clinic-ready tools for rapid surveillance
Members are discussing new tools designed for quick surveillance in clinical settings. These tools could significantly improve response times in healthcare.

Read more here

Looking for CE on family coaching skills
This thread is a resource for those seeking continuing education focused on enhancing family coaching skills. It’s valuable for professionals looking to improve patient interactions.

Read more here

Fitting nutrition into 15-minute appointments
A practical discussion on how to incorporate nutritional advice into short patient visits. This is crucial for maximizing the impact of limited consultation time.

Read more here

Rigorous pharmacovigilance CME recommendations
For those interested in pharmacovigilance, this thread offers recommendations for continuing medical education. It’s key for staying current with medication safety.

Read more here

Best CME for case-based neurology care plans
Explore recommendations for CME that focus on case-based learning in neurology. This approach helps in developing practical care plans.

Read more here

R3-ready GCP refresher recommendations
A discussion on the best resources for refreshing Good Clinical Practice knowledge, tailored for those preparing for R3 compliance updates.

Read more here


Thank you for being an active part of our community. Your contributions and discussions make this forum a valuable resource for all healthcare professionals.

Seeing RSV climb again, what helped us last winter was a 2-hour “respiratory-only” block right after lunch with curbside check-in and a HEPA at the entrance; it cut lobby crowding and kept well visits on time. Small caveat: it only flowed after we switched eConsent to a tablet form with a visible audit trail, otherwise intake jammed; tracking trends via Respiratory Syncytial Virus (RSV) | RSV | CDC helped us decide when to turn the block on/off. Anyone else batching respiratory visits or staggering them?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‍​‌‍‌‌‌‍​‌‌‍⁠​‌⁠‌​‌‍‍​‌‍​⁠‌‍​‌‌⁠​‍‌‍‌‌​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠​⁠​⁠‍​​⁠​‍​⁠‌⁠​⁠‍​​⁠‌⁠​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‌​⁠​‌​⁠​‍​⁠​‍​⁠​‍​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‍​‍‌​⁠‍​⁠‍‌​⁠‍​‌⁠‌‍‌‍‌​‌‌​​‌‌​‍‌​‌‌‌‍⁠⁠​⁠​‌‌‍⁠⁠‌​‍⁠‌​⁠‌​⁠​⁠‌⁠‌‌​‍​‍‌⁠⁠‌​

@Guide We added a 30-minute RSV-only evening window; SMS pre-check cut bottlenecks, staffing remains hard…

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‍​‌‍‌‌‌‍​‌‌‍⁠​‌⁠‌​‌‍‍​‌‍​⁠‌‍​‌‌⁠​‍‌‍‌‌​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠​⁠​⁠‍​​⁠​‍​⁠‌⁠​⁠‍​​⁠‌⁠​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‌​⁠​‌​⁠​‍​⁠​‍​⁠‌​​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌​‍⁠‌‍‌‍‌‍⁠‌‌​‌​‌​‌​​⁠​‍‌‌‌‌‌‍‍‍‌​⁠​‌⁠‍​​⁠‌‍‌‍​⁠‌⁠‌⁠‌​‌‌‌‌⁠⁠‌‍‌⁠​‍​‍‌⁠⁠‌​